Vycor Medical, Inc.
VYCO
$0.07
$0.00-1.71%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 416.90K | 513.80K | 496.40K | 436.40K | 455.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 416.90K | 513.80K | 496.40K | 436.40K | 455.20K |
| Cost of Revenue | 81.50K | 61.90K | 81.10K | 77.80K | 57.80K |
| Gross Profit | 335.40K | 451.90K | 415.30K | 358.50K | 397.40K |
| SG&A Expenses | 357.00K | 405.00K | 345.00K | 350.70K | 356.50K |
| Depreciation & Amortization | 14.90K | 14.90K | 14.90K | 14.90K | 14.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 453.40K | 481.70K | 445.20K | 449.20K | 435.90K |
| Operating Income | -36.50K | 32.10K | 51.10K | -12.80K | 19.30K |
| Income Before Tax | -62.40K | 5.00K | 25.70K | -38.50K | -6.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -62.40K | 5.00K | 25.70K | -38.50K | -6.70K |
| Earnings from Discontinued Operations | -300.00 | -100.00 | -1.80K | 0.00 | -100.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -62.70K | 4.90K | 23.90K | -38.60K | -6.70K |
| EBIT | -36.50K | 32.10K | 51.10K | -12.80K | 19.30K |
| EBITDA | -20.40K | 48.00K | 66.20K | 3.30K | 36.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 33.37M | 33.37M | 33.37M | 33.37M | 33.38M |
| Average Diluted Shares Outstanding | 33.37M | 33.37M | 38.67M | 33.37M | 33.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |